NLRP3 knockout, or a dysfunction of its key signalling components significantly reduces Aβ-induced microglial activation in vitro [135], decreases Aβ deposition or Tau pathology, and also alleviates cognitive impairment in AD mouse models [136,137]. This evidence concerns the gene MAPT and Alzheimer disease.